A detailed history of Acadian Asset Management LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 41,710 shares of DERM stock, worth $155,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,710
Previous 94,404 55.82%
Holding current value
$155,578
Previous $531,000 55.74%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$4.22 - $5.91 $222,368 - $311,421
-52,694 Reduced 55.82%
41,710 $235,000
Q2 2024

Aug 06, 2024

SELL
$3.31 - $5.94 $424,537 - $761,858
-128,259 Reduced 57.6%
94,404 $531,000
Q1 2024

May 10, 2024

BUY
$2.92 - $5.47 $567,615 - $1.06 Million
194,389 Added 687.52%
222,663 $817,000
Q4 2023

Feb 13, 2024

BUY
$2.7 - $7.96 $76,339 - $225,061
28,274 New
28,274 $162,000

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $43.3M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.